Annals of Cancer Research is an Open Access journal which gives information and aims to publish quality papers on preclinical, clinical, experimental therapeutics, anticipation and epidemiological involved in cancer study.

The main scope of the journal encompasses with cell cycle control, apoptosis, tumor pathology, molecular and cell biology, cancer therapy, genetics and genomics, cancer research, Cancer Immunology, translational therapeutics, cancer prevention, and epidemiology of cancer.

Annals of Cancer Research also covers cancer occurring in any part of the body including breast cancer, Lung Cancer, Ovarian Cancer, Liver Cancer and Skin Cancer …etc.

Subject Areas Involved:

Cancer Biology
  • Cellular and Molecular Biology
  • Tumor and stem cell biology
  • Tumor metabolism and Microenvironment
  • Types of Cancer
  • Cancer genetics and biomarkers
  • Tumor immunology
Treatment of Cancer
  • Radiation
  • Chemotherapy
  • Surgery
  • Targeted therapy
  • hormonal therapy
  • Cancer Risk Assessment
  • Cancer Statistics
  • Causes of Cancer
  • Prevention of cancer

Latest Articles

Pancreatic Cancer Incidence, Mortality, and Survival in the SEER 17 Southern and Total United States (2000-2008)
Subi Gandhi
Annals of Cancer Research 2017 4 : 2
Expression of circulating annexin A2 in hepatic diseases and hepatocellular carcinoma
Ebtesam El-Gezawy, Laila Abdelbaki, Mohamed Zeinel Deen, Sahar Eldeek, Marwa I. Abdelgawad
Annals of Cancer Research 2017 4 : 1
The role of simvastatin in inhibiting migration and proliferation of breast cancer cells through Rho/ROCK signaling pathway
Erwin Danil Yulian, Muchlis Ramli, Rianto Setiabudy, Nurjati Chairani Siregar, Arleni Bustami, Ricky Dosan
Annals of Cancer Research 2016 3 : 8
Spiritual pain from persistent chemotherapy-induced peripheral neuropathy in colon cancer patients in Japan
Ayumi Kyota, Kiyoko Kanda, Masako Honda, Kenji Nakazawa, Keiko Fujimoto
Annals of Cancer Research 2016 3 : 7
The intersection of chance with determinism: definitions and an application
Ken M Anderson, Marvin Rubenstein, Minu Patel
Annals of Cancer Research 2016 3 : 6
Aberrant NHERF1 expression as a biomarker in lung carcinoma
Deborah Belchis, Nathan Cuka, Neeraj Sharma, Rajni Sharma, Christopher D Gocke
Annals of Cancer Research 2016 3 : 5
Adjuvant intravesical instillation for primary intermediate and high-risk non-muscle invasive bladder cancer: BCG versus docetaxel
Hoda H Essa, Ahmed M Abd-Alrahim
Annals of Cancer Research 2016 3 : 4
Selective bladder preserving treatment by radiation therapy concurrent with either paclitaxel and cisplatin or cisplatin alone following a transurethral surgery
Reham Abdel-Wahab, Hoda H Essa, Ahmed Eltaher, Nagham N Omar, Mohamed A Aboziada
Annals of Cancer Research 2016 3 : 3
Concurrent radiation therapy and docetaxel in adjuvant treatment of locally advanced breast cancer
Samy M Algizawy, Hoda H Essa, AbdelNaser S Zaid
Annals of Cancer Research 2016 3 : 2
Short report
New York state health care provider participation in clinical trials: a brief report
Pathu Sriphanlop, Danielle M Crookes, Karen Demairo, Darryl Somayaji, Maureen Killackey, Anita McFarlane, Jean LePere, Lina Jandorf
Annals of Cancer Research 2016 3 : 1